WITHDRAWN: Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with antiretroviral therapy (Q39023337)

From Wikidata

Jump to navigation Jump to search

retracted scientific article published on 25 September 2010

Language	Label	Description	Also known as
English	WITHDRAWN: Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with antiretroviral therapy	retracted scientific article published on 25 September 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

retracted paper

0 references

WITHDRAWN: Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Lizette Gil

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Alicia Tarinas

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Dayme Hernández

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Beatriz Vega Riverón

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Daniel Pérez

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rolando Tápanes

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Virginia Capo

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jorge Pérez

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20951539

3 August 2024

publication date

25 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0753332210001459?httpAccept=text/xml

1 reference

10.1016/J.BIOPHA.2010.09.009

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.09.009

3 August 2024

https://api.elsevier.com/content/article/PII:S0753332210001459?httpAccept=text/plain

1 reference

10.1016/J.BIOPHA.2010.09.009

https://api.crossref.org/works/10.1016/J.BIOPHA.2010.09.009

3 August 2024

Biomedicine and Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocard infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Reactive oxygen species and nitric oxide in viral diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

The keys of oxidative stress in acquired immune deficiency syndrome apoptosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidative stress in human immunodeficiency virus infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Antioxidant status and lipid peroxidation in patients infected with HIV.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Increased Production of Malondialdehyde in Patients with HIV Infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Regulation of human immunodeficiency virus replication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidative stress in viral hepatitis and AIDS.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Effect of increase of dietary micronutrient intake on oxidative stress indicators in HIV/AIDS patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Biomarkers of free radical damage applications in experimental animals and in humans

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidant stress is increased during treatment of human immunodeficiency virus infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Strategies used by human immunodeficiency virus that allow persistent viral replication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Reactive oxygen species, cell signaling, and cell injury

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Contribution to characterization of oxidative stress in HIV/AIDS patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Characterization of T lymphocyte subset alterations by flow cytometry in HIV disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

The Human Immunodeficiency Virus Type 1 Tat Protein Potentiates Zidovudine-Induced Cellular Toxicity In Transgenic Mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.BIOPHA.2010.09.009

Identifiers

10.1016/J.BIOPHA.2010.09.009

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39023337&oldid=2220111631"